The amniotic products market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growth of orthobiologic treatment adoption, increasing sports injury incidence, expansion of minimally invasive treatment options, availability of amniotic-derived formulations, acceptance of biologic healing solutions.
The amniotic products market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for regenerative orthopedic therapies, rising focus on pain management alternatives, expansion of outpatient musculoskeletal treatments, growing investments in biologic product development, increasing clinical evidence supporting amniotic products. Major trends in the forecast period include increasing adoption of amniotic-based orthobiologics, rising use in sports medicine applications, expansion of injectable amniotic suspensions, growing focus on non-surgical healing therapies, enhanced integration with regenerative treatment protocols.
The rising demand for surgical procedures is expected to drive the growth of the amniotic products market going forward. Surgical procedures involve medical interventions performed by qualified surgeons to treat, repair, remove, or replace parts of the body affected by disease or injury. Amniotic products support these procedures by promoting tissue regeneration and healing, reducing inflammation at the surgical site, minimizing postoperative discomfort and pain, and enhancing overall tissue repair and protection. For example, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based plastic surgery organization, liposuction was the most commonly performed plastic surgery in 2023 with nearly 350,000 procedures - a 7% increase from 2022 - while hand surgeries totaled 207,887, up 2%, and maxillofacial surgeries reached 52,868, a 1% rise compared to the previous year. Therefore, the increasing volume of surgical procedures is fueling growth in the amniotic products market.
Major companies in the amniotic products market are focusing on the development of next-generation dual-layer amniotic allografts to enhance their product offerings and meet complex wound-care requirements. Dual-layer allografts consist of two layers of amniotic tissue, providing greater structural integrity, improved growth-factor retention, and extended resorption times, making them ideal for surgical wounds, burns, and chronic non-healing wounds. For instance, in June 2024, Ascension Biologics, a US-based tissue company, launched AMNIO MAXX®, a dual-layer amnion allograft that delivers twice the growth factors of traditional single-layer membranes, offers improved tensile strength, and allows flexible placement due to its orientation-independent design. AMNIO MAXX supports tissue regeneration and optimizes wound healing in complex surgical applications, exemplifying the technological innovations shaping the amniotic products market.
In August 2025, Legacy Medical Consultants, a US-based provider of amniotic allografts and advanced wound-care solutions, acquired the US rights to sell RedDress’s ActiGraft Pro for an undisclosed amount. Through this acquisition, Legacy Medical Consultants aims to expand its wound-care portfolio beyond amniotic products by adding a personalized, autologous treatment, strengthening its capabilities across hospitals, outpatient centers, and government healthcare settings. RedDress, an Israel-based company, specializes in autologous whole-blood clot wound-care technologies designed to support the healing of chronic, non-healing wounds.
Major companies operating in the amniotic products market are Stryker Corporation, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Lucina BioSciences LLC, Bioventus LLC, Organogenesis Inc., MiMedx Group, AlloSource, Orthofix US LLC, ACell Inc., Aziyo Biologics Inc., TissueTech Inc., Amino Technology LLC, LifeCell International Pvt. Ltd., Tissue Regenix Group plc, Aroa Biosurgery Limited, Skye Biologics Inc., Celularity Inc., NuVision Biotherapies Ltd., VIVEX Biologics Inc., Genesis Biologics Inc., Applied Biologics LLC, Next Biosciences, Surgenex LLC.
North America was the largest region in the amniotic products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the amniotic products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the amniotic products market by increasing costs of imported processing equipment, cryopreservation materials, biologic packaging, and quality testing inputs used in product manufacturing. North America and Europe are most affected due to reliance on imported biologic processing components, while Asia-Pacific faces higher costs for export-oriented amniotic formulations. These tariffs are raising production expenses and impacting pricing strategies. However, they are also encouraging local manufacturing, regional sourcing of biologic inputs, and innovation in cost-efficient amniotic product development.
The amniotic products market research report is one of a series of new reports that provides amniotic products market statistics, including amniotic products industry global market size, regional shares, competitors with a amniotic products market share, detailed amniotic products market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic products industry. This amniotic products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Amniotic products are ortho-biologic materials derived from the placenta, including amniotic membrane and amniotic fluid products, used to support tissue healing and reduce joint inflammation. When administered at the injury site, these products promote recovery by stimulating tissue regeneration and repair.
The main types of amniotic products include amniotic membranes and amniotic suspensions. Amniotic membranes are derived from the innermost layer of the placenta and consist of a thick basement membrane and an avascular stromal matrix. They are used as surgical dressings for burns, adjunctive tissue in oral cavity and bladder reconstruction, and procedures such as tympanoplasty, arthroplasty, omphalocele repair, as well as adhesion prevention in pelvic and abdominal surgeries. These products are applied across wound care, orthopedics, ophthalmology, and other medical fields, and are utilized in hospitals, ambulatory surgical centers, and specialty clinics.
The amniotic products market consists of sales of amniotic tissue matrix and amniotic fluid cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The amniotic products market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for regenerative orthopedic therapies, rising focus on pain management alternatives, expansion of outpatient musculoskeletal treatments, growing investments in biologic product development, increasing clinical evidence supporting amniotic products. Major trends in the forecast period include increasing adoption of amniotic-based orthobiologics, rising use in sports medicine applications, expansion of injectable amniotic suspensions, growing focus on non-surgical healing therapies, enhanced integration with regenerative treatment protocols.
The rising demand for surgical procedures is expected to drive the growth of the amniotic products market going forward. Surgical procedures involve medical interventions performed by qualified surgeons to treat, repair, remove, or replace parts of the body affected by disease or injury. Amniotic products support these procedures by promoting tissue regeneration and healing, reducing inflammation at the surgical site, minimizing postoperative discomfort and pain, and enhancing overall tissue repair and protection. For example, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based plastic surgery organization, liposuction was the most commonly performed plastic surgery in 2023 with nearly 350,000 procedures - a 7% increase from 2022 - while hand surgeries totaled 207,887, up 2%, and maxillofacial surgeries reached 52,868, a 1% rise compared to the previous year. Therefore, the increasing volume of surgical procedures is fueling growth in the amniotic products market.
Major companies in the amniotic products market are focusing on the development of next-generation dual-layer amniotic allografts to enhance their product offerings and meet complex wound-care requirements. Dual-layer allografts consist of two layers of amniotic tissue, providing greater structural integrity, improved growth-factor retention, and extended resorption times, making them ideal for surgical wounds, burns, and chronic non-healing wounds. For instance, in June 2024, Ascension Biologics, a US-based tissue company, launched AMNIO MAXX®, a dual-layer amnion allograft that delivers twice the growth factors of traditional single-layer membranes, offers improved tensile strength, and allows flexible placement due to its orientation-independent design. AMNIO MAXX supports tissue regeneration and optimizes wound healing in complex surgical applications, exemplifying the technological innovations shaping the amniotic products market.
In August 2025, Legacy Medical Consultants, a US-based provider of amniotic allografts and advanced wound-care solutions, acquired the US rights to sell RedDress’s ActiGraft Pro for an undisclosed amount. Through this acquisition, Legacy Medical Consultants aims to expand its wound-care portfolio beyond amniotic products by adding a personalized, autologous treatment, strengthening its capabilities across hospitals, outpatient centers, and government healthcare settings. RedDress, an Israel-based company, specializes in autologous whole-blood clot wound-care technologies designed to support the healing of chronic, non-healing wounds.
Major companies operating in the amniotic products market are Stryker Corporation, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Lucina BioSciences LLC, Bioventus LLC, Organogenesis Inc., MiMedx Group, AlloSource, Orthofix US LLC, ACell Inc., Aziyo Biologics Inc., TissueTech Inc., Amino Technology LLC, LifeCell International Pvt. Ltd., Tissue Regenix Group plc, Aroa Biosurgery Limited, Skye Biologics Inc., Celularity Inc., NuVision Biotherapies Ltd., VIVEX Biologics Inc., Genesis Biologics Inc., Applied Biologics LLC, Next Biosciences, Surgenex LLC.
North America was the largest region in the amniotic products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the amniotic products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the amniotic products market by increasing costs of imported processing equipment, cryopreservation materials, biologic packaging, and quality testing inputs used in product manufacturing. North America and Europe are most affected due to reliance on imported biologic processing components, while Asia-Pacific faces higher costs for export-oriented amniotic formulations. These tariffs are raising production expenses and impacting pricing strategies. However, they are also encouraging local manufacturing, regional sourcing of biologic inputs, and innovation in cost-efficient amniotic product development.
The amniotic products market research report is one of a series of new reports that provides amniotic products market statistics, including amniotic products industry global market size, regional shares, competitors with a amniotic products market share, detailed amniotic products market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic products industry. This amniotic products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Amniotic products are ortho-biologic materials derived from the placenta, including amniotic membrane and amniotic fluid products, used to support tissue healing and reduce joint inflammation. When administered at the injury site, these products promote recovery by stimulating tissue regeneration and repair.
The main types of amniotic products include amniotic membranes and amniotic suspensions. Amniotic membranes are derived from the innermost layer of the placenta and consist of a thick basement membrane and an avascular stromal matrix. They are used as surgical dressings for burns, adjunctive tissue in oral cavity and bladder reconstruction, and procedures such as tympanoplasty, arthroplasty, omphalocele repair, as well as adhesion prevention in pelvic and abdominal surgeries. These products are applied across wound care, orthopedics, ophthalmology, and other medical fields, and are utilized in hospitals, ambulatory surgical centers, and specialty clinics.
The amniotic products market consists of sales of amniotic tissue matrix and amniotic fluid cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Amniotic Products Market Characteristics
3. Amniotic Products Market Supply Chain Analysis
4. Global Amniotic Products Market Trends and Strategies
5. Amniotic Products Market Analysis of End Use Industries
7. Global Amniotic Products Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Amniotic Products Total Addressable Market (TAM) Analysis for the Market
9. Amniotic Products Market Segmentation
10. Amniotic Products Market Regional and Country Analysis
11. Asia-Pacific Amniotic Products Market
12. China Amniotic Products Market
13. India Amniotic Products Market
14. Japan Amniotic Products Market
15. Australia Amniotic Products Market
16. Indonesia Amniotic Products Market
17. South Korea Amniotic Products Market
18. Taiwan Amniotic Products Market
19. South East Asia Amniotic Products Market
20. Western Europe Amniotic Products Market
21. UK Amniotic Products Market
22. Germany Amniotic Products Market
23. France Amniotic Products Market
24. Italy Amniotic Products Market
25. Spain Amniotic Products Market
26. Eastern Europe Amniotic Products Market
27. Russia Amniotic Products Market
28. North America Amniotic Products Market
29. USA Amniotic Products Market
30. Canada Amniotic Products Market
31. South America Amniotic Products Market
32. Brazil Amniotic Products Market
33. Middle East Amniotic Products Market
34. Africa Amniotic Products Market
36. Amniotic Products Market Competitive Landscape and Company Profiles
37. Amniotic Products Market Other Major and Innovative Companies
40. Amniotic Products Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Amniotic Products Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses amniotic products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for amniotic products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amniotic products market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Amniotic Membranes; Amniotic Suspensions2) By Application: Wound Care; Orthopedics; Ophthalmology; Other Applications
3) By End-Use: Hospitals And Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Amniotic Membranes: Dehydrated Amniotic Membranes; Cryopreserved Amniotic Membranes2) By Amniotic Suspensions: Liquid Amniotic Suspensions; Lyophilized Amniotic Suspensions
Companies Mentioned: Stryker Corporation; Smith & Nephew plc; Integra LifeSciences Holdings Corporation; Lucina BioSciences LLC; Bioventus LLC; Organogenesis Inc.; MiMedx Group; AlloSource; Orthofix US LLC; ACell Inc.; Aziyo Biologics Inc.; TissueTech Inc.; Amino Technology LLC; LifeCell International Pvt. Ltd.; Tissue Regenix Group plc; Aroa Biosurgery Limited; Skye Biologics Inc.; Celularity Inc.; NuVision Biotherapies Ltd.; VIVEX Biologics Inc.; Genesis Biologics Inc.; Applied Biologics LLC; Next Biosciences; Surgenex LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Amniotic Products market report include:- Stryker Corporation
- Smith & Nephew plc
- Integra LifeSciences Holdings Corporation
- Lucina BioSciences LLC
- Bioventus LLC
- Organogenesis Inc.
- MiMedx Group
- AlloSource
- Orthofix US LLC
- ACell Inc.
- Aziyo Biologics Inc.
- TissueTech Inc.
- Amino Technology LLC
- LifeCell International Pvt. Ltd.
- Tissue Regenix Group plc
- Aroa Biosurgery Limited
- Skye Biologics Inc.
- Celularity Inc.
- NuVision Biotherapies Ltd.
- VIVEX Biologics Inc.
- Genesis Biologics Inc.
- Applied Biologics LLC
- Next Biosciences
- Surgenex LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.17 Billion |
| Forecasted Market Value ( USD | $ 1.65 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
